Centene Corporation (LON:0HVB)
London
· Delayed Price · Currency is GBP · Price in USD 30.16
-0.70 (-2.27%)
At close: Jul 15, 2025
Centene Revenue
Centene had revenue of $42.88B USD in the quarter ending March 31, 2025, with 16.58% growth. This brings the company's revenue in the last twelve months to $153.27B, up 7.22% year-over-year. In the year 2024, Centene had annual revenue of $147.17B with 4.09% growth.
Revenue (ttm)
$153.27B
Revenue Growth
+7.22%
P/S Ratio
0.09
Revenue / Employee
$2.53M
Employees
60,500
Market Cap
11.15B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.17B | 5.78B | 4.09% |
| Dec 31, 2023 | 141.39B | 5.39B | 3.97% |
| Dec 31, 2022 | 136.00B | 17.43B | 14.70% |
| Dec 31, 2021 | 118.57B | 14.29B | 13.71% |
| Dec 31, 2020 | 104.28B | 33.47B | 47.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Centene News
- 3 days ago - CNC FRAUD ALERT: Centene Corporation 40% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by September 8 (NYSE:CNC) - GlobeNewsWire
- 4 days ago - NYSE: CNC: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Centene Corporation - Business Wire
- 4 days ago - Levi & Korsinsky Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 – CNC - GlobeNewsWire
- 4 days ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Centene Corporation (CNC) Investors To Inquire About Securities Fraud Class Action - Business Wire
- 4 days ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Centene Corporation (CNC) - GlobeNewsWire
- 4 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene - GlobeNewsWire
- 4 days ago - INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Centene Corporation (CNC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewsWire
- 4 days ago - Shareholders that lost money on Centene Corporation(CNC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More - PRNewsWire